Regulation And Legal
Orbicular Secures Health Canada Nod for Ozempic
Orbicular’s generic semaglutide injection received a Notice of Compliance from Health Canada, its second G‑7 regulator approval after U.S. FDA tentative approval.
The product, co‑developed with Apotex
